PULM
NASDAQ
$1.68
Pulmatrix Inc (PULM)
Pulmatrix, Inc., a clinical-stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company is headquartered in Lexington, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Target: $10 (+495.24%)
Market Cap
$5.73M
Free Cash Flow Yield
-81.74%
Beta (5Y)
0.42
Price Chart
Valuation
Market Cap$5.73M
P/S2459.21
P/B2.24
Profitability
Gross Profit (TTM)-$38K
EBITDA-$4.53M
EPS-$1.24
Financial Health
Free Cash Flow Yield-81.74%
Growth & Risk
EPS 5Y CAGR-34.28%
FCF 5Y CAGR-24.39%
Beta (5Y)0.42
Sharpe Ratio-1.11